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Solution Structure of a Cyanovirin-N:Man1-2Man
Complex: Structural Basis for High-Affinity
Carbohydrate-Mediated Binding to gp120
5]; thus, high-resolution structural studies illuminating
the details of CVN:gp120 binding are of significant inter-
est. High-resolution structures of free CVN have been
solved for the monomer by NMR ([6]; Figure 1a), for the
domain-swapped dimer by X-ray crystallography at low
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Bethesda, Maryland 20892 pH [7], and by NMR at neutral pH [8]. CVN is unique in
that it contains dual elements of 2-fold symmetry; the
sequence comprises two well-conserved 50 amino acid
repeats (Figure 1b), and the three-dimensional structureSummary
comprises two pseudosymmetrical domains where one
domain is formed by amino acids 1–39 and 91–101, andBackground: Cyanovirin-N (CVN) is a novel, 11 kDa cy-
the second domain is formed by amino acids 40–90anobacterial protein that potently inhibits viral entry by
(Figures 1a and 1c; [6]). CVN has a simple yet novel folddiverse strains of HIV through high-affinity carbohy-
in which the back of the protein (as presented in Figuredrate-mediated interactions with the viral envelope gly-
1a) contains two adjacent triple-stranded antiparallel coprotein gp120. CVN contains two symmetry-related
sheets (1–3 and 6–8), and the front of the protein iscarbohydrate binding sites of differing affinities that se-
formed by two opposing  hairpins (4,5 and 9,10). Alectively bind to Man8 D1D3 and Man9 with nanomolar
single 310-helical turn precedes each of these structuralaffinities, the carbohydrates that also mediate CVN:gp120
elements, and a 4 residue linker connects the sequentialbinding. High-resolution structural studies of CVN in
domains.complex with a representative oligosaccharide are de-
It has been well established that the potent anti-HIVsirable for understanding the structural basis for this
activity of CVN stems from high-affinity and high-avidityunprecedented specificity.
interactions with the surface-envelope glycoprotein
gp120 and thus acts at the level of HIV envelope-medi-Results: We have determined by multidimensional het-
ated fusion [1, 2, 5]. For HIV, viral entry is orchestratederonuclear NMR spectroscopy the three-dimensional
by a series of recognition events including the bindingsolution structure of CVN in complex with two equiva-
of the virus to target cells via gp120-CD4 interactions,lents of the disaccharide Man1-2Man, a high-affinity
subsequent interactions between gp120 and the chemo-ligand which represents the terminal-accessible disac-
kine receptors CXCR4 and CCR5 (generically referredcharide present in Man8 D1D3 and Man9. The structure
to as coreceptors), and ultimately, membrane fusionreveals that the bound disaccharide adopts the stacked
mediated by the transmembrane subunit of the HIV-conformation, thereby explaining the selectivity for Man8
envelope protein gp41 [9]. CVN can exert its fusion-D1D3 and Man9 over other oligomannose structures,
blocking activity at more than one stage of this viraland presents two novel carbohydrate binding sites that
entry process [2].account for the differing affinities of the two sites. The
The HIV-envelope protein gp120 is heavily glycosy-high-affinity site comprises a deep pocket that nearly
lated with an overall abundance of Asn-linked complexenvelops the disaccharide, while the lower-affinity site
carbohydrates [10]. It has recently been shown that CVNcomprises a semicircular cleft that partially surrounds
selectively recognizes and binds with nanomolar affinitythe disaccharide. The40 A˚ spacing of the two binding
the D1D3 isomer of Man8 and Man9 (Figure 1d) withsites provides a simple model for CVN:gp120 binding.
similar nM affinities as observed for CVN binding to
gp120 and that stoichiometric amounts of Man8 D1D3Conclusions: The CVN:Man1-2Man complex pro-
or Man9 can compete directly with gp120 for CVN bind-vides the first high-resolution structure of a mannose-
ing [4]. On the basis of the nanomolar selectivity forspecific protein-carbohydrate complex with nanomolar
Man8 D1D3 and Man9, we used the disaccharide Man1-affinity and presents a new carbohydrate binding motif,
2Man, which exemplifies the structure of the terminalas well as a new class of carbohydrate binding protein,
branches specific to mammalian high-mannose oligo-that facilitates divalent binding via a monomeric protein.
saccharides, to show by NMR that CVN contains two
novel Man1-2Man binding sites located on opposite
Introduction ends of the long axis of the protein (Figure 1a; [4]). NMR
and isothermal titration calorimetry experiments further
Cyanovirin-N (CVN) is a novel cyanobacterial protein demonstrated that these binding sites exhibit differing
that potently inactivates (IC50  1 nM) diverse strains of affinities for the disaccharide with Ka of 7.2 ( 4)  106human and simian immunodeficiency viruses (HIV and M1 and 6.8 ( 4)  105 M1 for the high- and low-
SIV) [1] at the level of envelope-mediated fusion through affinity sites, respectively. In the present paper, by using
nanomolar-affinity interactions with the surface-enve- multidimensional NMR spectroscopy, we have deter-
lope glycoprotein gp120 [1–4]. CVN is currently under mined the solution structure for the 1:1 CVN:Man1-
preclinical investigation as an antiviral microbicide [2,




2Man complex in which only the high-affinity site is
occupied by the disaccharide, and we have calculated
a model structure for the 1:2 CVN:Man1-2Man com-
plex in which both the high-and low affinity sites are
occupied. The structure readily explains the selective
recognition of Man8 D1D3 and Man9 over other oligo-
mannose structures, reveals the structural basis for the
observed nM equilibrium dissociation constants, and
provides a model of CVN:gp120 binding that is consis-
tent with various reported biochemical findings.
Results
Stucture Determination
We previously showed that the disaccharide Man1-
2Man is in slow exchange on the NMR time scale when
bound through the high-affinity site and that it is in inter-
mediate exchange when bound through the low-affinity
site [4]. We therefore recorded two sets of multidimen-
sional double- and triple-resonance isotope-separated
and -filtered NMR data; first, we used the 1:1 complex
in which the disaccharide is bound exclusively through
the high-affinity site, and second, we used the 1:2
CVN:Man1-2Man complex in which both carbohy-
drate binding sites are occupied. An example of the
quality of the data is provided in Figure 2a by a compos-
ite of 13C strips taken from three-dimensional 12C filtered/
13C separated NOE experiments illustrating intermolecu-
lar contacts between protons attached to 13C on the 13C
labeled proteins and protons attached to 12C on the
unlabeled disaccharide. Measurement of residual 1DNH
dipolar couplings [11] for the 1:1 CVN:Man1-2Man
complex demonstrated that the backbone of the protein
is not altered upon complex formation (see Experimental
Procedures). In addition, a direct comparison of the
three-dimensional 15N separated NOE and quantitative
Figure 1. Structure and Sequence of CVN Showing Dual ElementsJ-coupling experiments [12] on the 1:1 complex with
of 2-Fold Symmetryequivalent spectra for free CVN indicated that only those
(a) Ribbon diagram of CVN showing the pseudosymmetry of theresidues whose interfacial side chains are directed into
protein with the high-affinity mannose binding domain (Ile40–His90)the high-affinity site are altered in the presence of
colored green and the low-affinity domain (Leu1–Val39 and Ile91–Man1-2Man. Owing to this preservation of structure,
Glu101) colored blue. The locations of each domain were determined
we used the recently described procedure of conjoined previously by NMR chemical-shift mapping experiments using
rigid-body/torsion-angle dynamics [8, 13, 14] to deter- Man1-2Man; side chains that are directed into the mannose bind-
ing site for each domain are displayed as rods. (Figure was gener-mine the structure of the complex. In this method, the
ated with the program RIBBONS [35].)backbone and noninterfacial side chains of CVN are
(b) Alignment of the two conserved sequential repeats occurring infixed while the torsion angles of the disaccharide and
the CVN sequence.the interfacial side chains of CVN are free to move, and
(c) Alignment on the basis of the two structural domains of CVN as
the disaccharide is free to translate and rotate relative described in (a) above. Residues whose side chains interact with
to CVN subject to experimental distance and torsion- the disaccharide are highlighted with yellow boxes.
(d) Chemical structure of Man9GlcNAc2 where bold labels indicateangle restraints (Table 1). The final 25 simulated anneal-
standard numbering of the monosaccharides present in oligoman-ing structures of the complex of the high-affinity site
nose. The three arms are labeled with standard notation as D1, D2,best fitted to the protein backbone are shown in Figure
and D3, and the numerical subscript indicates the total number of2b and display an overall precision of 0.38 A˚ for the
mannopyranose rings per oligomannose structure. Thus, the com-
disaccharide and interfacial side chains (Table 1). In position of Man6 and isomers of Man7 and Man8 can be deduced
the case of the low-affinity site of the 1:2 CVN:Man1- by removing appropriate mannopyranose termini from the relevant
arm of Man9.2Man complex, line broadening is observed for those
residues bearing interfacial side chains, and many fewer
intermolecular NOEs were observed relative to the high-
affinity site. In order to calculate a model of the low-affinity experimental versus symmetry-based distance and di-
hedral-angle restraints used in the calculations, and thesite, additional distance and dihedral-angle restraints were
introduced on the basis of symmetry between the two best fit of the final 25 simulated annealing structures of
the low-affinity site is shown in Figure 2d. The decreasedomains (Figure 1). Table 2 presents a summary of the
Cyanovirin-N:Man1-2Man Complex
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Figure 2. Spectral Data, Superpositions, and Potential Hydrogen Bonding Network for the CVN:Man1-2Man Complex
(a) A composite of representative 13C-H strips taken from a 3D 12C filtered/13C separated NOE spectrum in the presence of 1 equivalent of
Man1-2Man (top panel, mixing time 150 ms) and 2 equivalents of the disaccharide (bottom panel, mixing time 150 ms). Man1-2Man
bound through the high-affinity site is in slow exchange on the NMR time scale, while the disaccharide bound through the low-affinity site is
in intermediate exchange leading to extensive line broadening for interfacial residues residing in the low-affinity domain.
(b) Stereo view showing best-fit superpositions of the final 25 structures of the high-affinity domain bound to Man1-2Man where the protein
backbone is colored blue, the interfacial side chains of the high-affinity site are colored red, and the Man1-2Man disaccharide is colored
green.
(c) Schematic showing the potential hydrogen bonding network between mannose hydroxyls, interfacial side chains, and proximal polar
residues (for example, Asn37 and Gln50) of the high-affinity domain. Solid arrows indicate distances between donor and acceptor atoms that
allow for direct hydrogen bonds, and dashed arrows denote distances that would accommodate water-mediated hydrogen bonds.
(d) Stereo view showing best-fit superpositions of the final 25 simulated structures of the low-affinity domain bound to Man1-2Man with
the protein backbone in blue, interfacial side chains in red, and disaccharide in green. Note that the ensemble for the low-affinity site is a
model calculated from a combination of experimentally determined distance and dihedral-angle restraints from the several interfacial residues
that are not exchange broadened and from distance restraints introduced on the basis of symmetry of the two domains (summarized in Tables
1 and 2). Figures 2b and 2d were generated using the program VMD-XPLOR [36].
in precision (0.58 A˚) for the disaccharide and interfacial insert into a deep cleft that constitutes the high-affinity
site. From the view shown in Figures 3a and 3b, theside chains in the low-affinity site relative to the high-
affinity site reflects the limited number of restraints used nonreducing mannopyranose ring is located in the top
of the binding site and oriented so that all of the hydroxylin calculating the model.
groups interact via potential hydrogen bonds, direct or
water-mediated (Figure 2c), with polar or charged resi-Structure of Man1-2Man Bound
through the High-Affinity Site dues forming the top rim of the cleft. These include the
carboxylate of Glu41 located on  strand 4 (Figures 1aBoth mannopyranose rings of the disaccharide adopt a
chair conformation, and the nonreducing pyranose ring and 3a), the hydroxyl of Ser52 located in the 4 amino
acid linker that connects the two sequential domains ofis stacked over the reducing mannopyranose to yield
respectiveφ/ angles of 48 and 42, values that fall the protein, and the amide and carboxylate groups of
Asn53 and Glu56 presented by the third 310-helical turn.within one of the two most preferred conformations for
this disaccharide [15]. Both rings of the disaccharide (The involvement of residues Ser52, Asn53, and Glu56
Structure
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Table 1. Structural Statistics
High-Affinity Site Low-Affinity Sitea
Distance restraints
Intermolecular NOEs 37 26
Intermolecular hydrogen bonds 4b
Intramolecular NOEs
Protein (interfacial side chains) 8 5
Disaccharide 10 10
Torsion angle restraints
Interfacial side chains of the proteinc 18 8
Disaccharided 38 38
Rms deviations from distance restraintse 0.155 (0.027) 0.061 (0.209)
Rms deviations from dihedral angle restraintse 0.333 (0.190) 0.290 (0.047)
Coordinate precision (A˚)f
Interfacial side chains and disaccharide 0.38 (0.06) 0.58 (0.15)
Disaccharide 0.28 (0.12) 0.62 (0.18)
Interfacial side chains 0.39 (0.07) 0.50 (0.20)
a See Table 2 for breakdown of experimental versus symmetry-related distance restraints used in calculating the low-affinity site.
b Intermolecular distance restraints (3–5 A˚) for N and O atoms of the side chains of Lys3, Gln6, Glu23, and Thr25 to the disaccharide were
introduced on the basis of symmetry and to facilitate convergence.
c Interfacial side chain dihedral angle restraints were determined experimentally from 15N separated NOE and quantitative J coupling experiments.
d The dihedral angle restraints used in the structure calculations for the disaccharide are consistent with a chair conformation for the individual
mannopyranose units and were introduced on the basis of intradisaccharide NOEs observed in a 2D 12C filtered NOE spectrum. Resonances
for the disaccharide bound through the high-affinity site and the low-affinity site are degenerate as observed in the 12C filtered NOE spectra
of 1:1 and 1:2 CVN:Man1-2Man complexes; thus, the same dihedral angle restraints were used in calculating the bound structures of each
disaccharide. No dihedral angle restraints were used for the linker atoms.
e None of the final set of 25 structures exhibited distance violations greater than 0.2 A˚ or dihedral angle violations greater than 5.
f The precision of the coordinates is defined as the average rms difference between the 25 individual structures and the mean coordinate
positions for each site of the complex obtained by best fitting to the protein backbone. (Note the protein backbone and noninterfacial side
chains are held fixed.)
might explain the loss of activity reported for an internal so that its methyl group is flanked by and in van der
Waals’ contact with the C-6 protons of each pyranosedomain-swapped mutant in which this sequence is inter-
rupted but the overall wild-type fold is preserved [16].) ring as well as H5	 of the nonreducing pyranose.
Thr57 bisects the binding site and is perfectly positioned A subtle feature of the 3D structure of CVN is the
gentle twist of the second and fifth  turns (connecting
 strands 1,2 and 7,8, respectively, and located at oppo-
Table 2. Restraints for Calculation of Low-Affinity Site site end of the protein) away from the planes of their
respective triple-stranded antiparallel  sheets and to-
Low-Affinity Site
Symmetry-Related
Residue in High- ward the opposing  hairpins formed by strands 9,10
Affinity Site for and 4,5 (Figure 1a). As seen in the high-affinity site (Fig-
which Equivalent ures 3a and 3b), the backbone of the turn that connects
Intermolecular
strands 7 and 8, together with those side chains thatAtom Residue Man1-2Man NOE Is Observed
are directed into the binding site (Lys74, Arg76, and
Experimental NOE restraints Gln78), form the bottom of the cleft that envelops the
K3 C
H2 H4	, H6a/b	 N53 reducing mannopyranose ring. Thus, the carbonyl oxy-
Q6 CH2 H4	, H6a/b	 E56 gen atoms of Lys74 and Thr75, the amino of Lys74, the
CH2 H6a	 guanidinium group of Arg76, and the amide of the side
T7 CH H5	, H6a/b	 T57 chain of Gln78 are responsible for the electrostatic inter-CH3a H4, H5, H4	, H5	,
actions that govern binding of the reducing pyranoseH6a	, H6b	
of the disaccharide (see Figure 2c for a schematic ofT25 CH H5/H6b R76
A92 CH3 H2	, H3	 potential hydrogen bonds). The side chain of Asn42 lines
I94 C
H3 H2, H2	, H3	 V43 the back of the cleft with the H
 atoms of the amide
group within direct hydrogen bonding distance (2 A˚)Intermolecular distance restraints added on the basis
of symmetry of the carbonyl oxygen atom of Lys74. Although the
hydrogen bond donor and acceptor atoms of the sideK3 CεH2 H4	, H6a/b	 N53
chains of Asn42 and Asp44, as well as those of Asn37E23 CH2 H6a/b	 K74
CH2 H5	, H6a/b	 (which is located on the opposite side of the protein in
N93 CH2 H2	, H3	 N42 the low-affinity domain), are not in direct contact with
the disaccharide, the side chains of these residues likelya Although the CH3 signals for T7 and T57 are degenerate in both
free and disaccharide-bound CVN, upon addition of a second equiv- augment the extensive hydrogen bonding network seen
alent of disaccharide, which binds through the low-affinity site, the in the high-affinity site by potentially forming hydrogen
NOE intensity for this resonance increased by 50%, allowing as- bonds with residues directly contacting the disaccha-
signment of these intermolecular distance restraints for T7 CH3. ride (Figure 1c). Thus, a total of 17 potential hydrogen
Cyanovirin-N:Man1-2Man Complex
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Figure 3. Views Illustrating the Interactions between CVN and Man1-2Man
(a) Bonds representation of the high-affinity site where the protein backbone and interfacial side chains are colored dark and light green,
respectively; the disaccharide is colored yellow; and N and O atoms appear as blue and red spheres, respectively. The equivalent representation
of the low-affinity site is shown in (c) with the protein backbone and interfacial side chains colored dark blue and light blue, respectively.
Surface representations of the disaccharide bound to CVN through (b) the high-affinity site and (d) the low-affinity site. Surfaces for Asp and
Glu are colored red; Arg and Lys are blue; Asn, Gln, Ser, and Thr are light blue; and methyl groups within van der Waals’ contact with the
disaccharide are green. The disaccharide is drawn in yellow bonds with oxygen atoms colored red. This figure was generated with the
programs MolMol [37] and GRASP [38] by using the restrained regularized-mean structure of the complex.
bonds, direct or possibly water-mediated, can be ac- binding site due to electrostatic interactions with the
counted for in the structure of the complex of the high- guanidinium group of Arg25 (data not shown) observed
affinity site leading to nanomolar affinity for the disac- here and in both NMR [6] and X-ray structures [7] of
charide [4]. free CVN. Thus, a semicircular ridge formed by Lys3,
Gln6, Thr7, Glu23, and Thr25 constitutes the bulk of the
low-affinity site (right side as shown in Figures 3c andModel of Man1-2Man Bound through the Low-
3d) in comparison to the deep pocket revealed in theAffinity Site
high-affinity site. (For comparison, the values of the totalThe approximate 10-fold reduction in affinity for Man1-
accessible surface area buried upon binding of Man1-2Manbound through the low-affinity site [4] is apparent
2Man through the high- and low-affinity domains arefrom the model shown in Figures 3c and 3d where the
550 A˚2 versus 460 A˚2, respectively.) Equivalent tobinding pocket appears to be half missing relative to the
Thr57 in the high-affinity site, the methyl protons of Thr7deep cleft forming the high-affinity site. This difference
in the low-affinity site make hydrophobic contacts witharises from the substitution of three key polar interfacial
the methylene protons of C6 and C6	. However, in con-residues present in the symmetry-related high-affinity
trast to Thr57, NOEs are observed between the H atomdomain by three nonpolar residues in the low-affinity
of Thr7 and H5	, H6a	, and H6b	 (Figure 2a), indicatingdomain. Specifically, Glu41, Ser52, and Gln78 of the
that the disacaccharide adopts a slightly shifted positionhigh-affinity domain have been replaced, respectively,
in the low-affinity site relative to that in the high-affinityby Ala92, Gly2, and Gly27 in the low-affinity domain. In
site, or that the side chain of Thr7 is freely rotating, oraddition, although the presence of Asp95 in the low-
both. Nonetheless, differences between the two sitesaffinity domain is equivalent to Asp44 of the high-affinity
must be subtle as indicated by degenerate chemicaldomain (which is involved in at least three potential
shifts for both equivalents of the disaccharide in the 1:2hydrogen bonds contributing to the binding of the disac-
charide), Asp95 is directed away from the carbohydrate CVN:Man1-2Man complex.
Structure
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Specificity for Man8 D1D3 and Man9 oligosaccharides (Figure 4) present in abundance on
gp120 is consistent with these findings.CVN selectively binds with nanomolar affinity to Man8
D1D3 and Man9 [4] but does not bind with measurable Since CVN contains one high-affinity carbohydrate
binding site (through which oligomannose is bound ex-affinity to Man7, Man6, or Man5, nor to the monosaccha-
ride -D-mannose [4, 17]. This novel selectivity can be clusively at nanomolar concentrations [4]) as well as a
second lower-affinity binding site, a probable mecha-explained by the structure of the CVN:Man1-2Man
complex. Most protein-carbohydrate interactions are nism for CVN:gp120 interactions would include initial
binding to Man8 D1D3 or Man9 via the high-affinity site.characterized by electrostatic interactions between
amino acids located on the outer surfaces or within Once bound through the high-affinity site, the local con-
centration of Man8 or Man9 will be high in order thatshallow carbohydrate binding sites on the protein that
lead to modest Kds in the micromolar to millimolar range. binding to a second Man8 or Man9 residue that is appro-
priately spaced (40 A˚, Figure 4a) relative to the oligo-In stark contrast, the high-affinity, and to a lesser extent
the low-affinity, carbohydrate binding sites of CVN are saccharide bound through the high-affinity site will oc-
cur. Divalent binding wherein two branches of a singleperfectly shaped to nearly engulf the stacked conforma-
tion of the disaccharide Man1-2Man. Moreover, the oligomannose residue occupy both carbohydrate bind-
ing sites in a single CVN molecule is impossible due toorientation of the bound disaccharide directs the C-1
hydroxyl of the reducing sugar away from, but still proxi- the 40 A˚ separation of the carbohydrate binding sites
in CVN relative to the 18 A˚ that separates the high-mal to, the binding site. The notable difference between
the structures of Man8 D1D3 and Man9 and other high- affinity D1 and D3 arms of Man8 D1D3 and Man9 (illus-
trated in Figure 9 of [4]). (The flexibility of Man8 andmannose structures is the presence of the full-length D1
and D3 arms which, unlike the D2 arm (or the equivalent Man9 relative to the Asn-linked core combined with the
inherent presence of two high-affinity arms will increaseMan1-2Man branch of Man6; Figure 1d) present a
sterically unhindered Man1-2Man terminus. (This dif- the diversity of proximal high-mannose residues on
gp120 to which CVN can bind.) Thus, binding to oligo-ference arises from the additional mannose unit of the
D1 arm, or the additional methylene unit characteristic mannose, whether free or attached to gp120, through
both carbohydrate binding sites will result in multivalentof a 1-6 glycosidic linkage, that separates the terminal
disaccharide from the more bulky mannopyranose rings binding that can facilitate crosslinking (and is observed
with Man8 and Man9 at micromolar to millimolar concen-that constitute the branch points, namely M3 and M4	;
see Figure 1d.) Thus, the specificity for the stacked di- trations [4]).
Two effective mechanisms for inhibiting HIV fusionsaccharide together with the composition of the next-
most reducing sugar give rise to the unique specificity might include (1) blocking the binding sites of the recep-
tors and coreceptors required for viral attachment andof CVN for Man8 D1D3 and Man9, since the presence of
a bulky sugar (such as M4	, which acts as the branch subsequent conformational changes within the enve-
lope proteins associated with envelope-mediated fusionpoint for the D2 and D3 arms) will prevent the terminal
disaccharide from entering the binding site due to steric and (2) locking the envelope proteins into a prefusogenic
state. As shown in the model in Figure 4b, carbohydrate-clash with the bottom rim of the binding sites as pre-
sented in Figure 3. Unpublished NMR titration experi- mediated binding of CVN to gp120 through only the high-
affinity site may sterically block subsequent binding ofments (C.A.B.) using Man6 and the D1 isomer of Man7
demonstrated that no detectable chemical shift pertur- target cell receptors given the size of CVN (55 A˚ in
length by 25 A˚ across). On the other hand, if boundbations in, and therefore no appreciable binding to, CVN
are observed in the presence of up to four equivalents through both carbohydrate binding sites (right side of
Figure 4b), CVN would be expected to also limit theof either of these oligosaccharides. Thus, the conforma-
tion of the terminal disaccharide (which has been shown conformational flexibility of the gp120 trimer, perhaps
fixing it in a prefusogenic conformation. Either modelby NMR to be dependent on the presence of terminal
pyranose rings [18]), in addition to its chemical composi- reconciles the findings that addition of CVN both prior
and subsequent to exposure to CD4 blocks envelope-tion, appears to be important for high-affinity binding.
mediated fusion [2]; and given the oligomeric nature of
fusogenic gp120 (the generally accepted trimeric model
Implications of the Structure for CVN Binding of Kwong et al. [21] is shown in Figure 4b), the crosslink-
to gp120 ing model most elegantly explains the finding that two
A variety of biochemical and cell-fusion experiments equivalents of CVN are sufficient to block envelope-
have illuminated facets of the mechanism of action of mediated fusion [4, 19].
the anti-HIV activity of CVN. These include the findings
that pretreatment of the viral envelope with CVN can
inhibit subsequent binding of gp120 to CD4 [2, 5, 19], Comparison with Other Mannose Binding Proteins
In comparison with other mannose-specific carbohydrateto the chemokine receptors CXCR4 [19] and CCR5 [2],
and to the carbohydrate-dependent neutralizing anti- binding proteins, or lectins, CVN differs in several ways.
First, the carbohydrate binding sites seen in the cocrys-body 2G12 [5, 20]. CVN also inhibits several other unre-
lated enveloped viruses [1, 2], and cell-fusion experi- tal structures of two unrelated, well-studied mannose-
specific plant and animal lectins, namely concanavalinments have shown that Man8 D1D3 and Man9 can
directly compete with gp120 for CVN binding [4]. A A [22] and the Ca2-dependent mannose binding protein
MBP-A [23], reveal relatively shallow carbohydrate bind-model of CVN bound to gp120 through high-mannose
Cyanovirin-N:Man1-2Man Complex
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Figure 4. Model of CVN:oligomannose and
CVN:gp120 Binding
(a) Model of CVN bound to Man9 through the
high-affinity site. The model was generated
by replacing the coordinates of the disaccha-
ride with those of Man9 [39] after best-fitting
the terminal Man1-2Man disaccharide of
the D1 arm of Man9 to the coordinates of the
equivalent disaccharide bound through the
high-affinity site in the 1:2 CVN:Man1-
2Man complex. CVN appears as a surface
(generated using the program GRASP) with
the high-affinity site colored green and the
low-affinity site colored blue. The two Man1-
2Man disaccharides are shown as yellow
bonds, and the remainder of Man9 are shown
as gray bonds. For clarity, the D2 arm of Man9
is not shown.
(b) Model illustrating two possible modes of
high-mannose-mediated binding of CVN to
trimeric gp120. In the left panel, CVN is bound
through the high-affinity site to a single Man9
on one gp120 monomer of the gp120 trimer.
In the right panel, CVN is shown binding to
two Man9 units emanating from two gp120
monomers wherein both carbohydrate bind-
ing sites on CVN are occupied. The model of
trimeric gp120 (PDB accession code 1gc1)
was generated as described by Kwong et al.
[21], after which the coordinates of Man9 were
linked to the N
 atom of those Asn residues
known to display high-mannose oligosaccharides [40, 41]. CVN, gp120, and Man9 are represented as red, green, and blue surfaces, respectively,
and the trimer is shown from the view of the virus looking toward the target cell. CD4 is shown as a yellow C worm.
ing sites formed by charged and polar residues residing pates only in carbohydrate binding, not Ca2 ligation.
Last, in addition to the specificity that accompaniesin loops. These minimal binding sites are representative
of most protein-carbohydrate interactions and account recognition of a particular mono- or oligosaccharide
structure, carbohydrate binding proteins augment bothfor the observation that lectins typically bind their mono-
and disaccharide ligands with very weak affinities (dis- specificity and affinity through multivalent interactions
that arise due to their dimeric to oligomeric nature. Forsociation constants in the 0.1–10 mM range). In the case
of CVN, the high-affinity binding site in particular forms example, at neutral pH, concanavalin A exists as a tetra-
mer in which the individual carbohydrate binding sitesa deep polar pocket that nearly surrounds the high-
affinity ligand Man1-2Man (Figures 3a and 3b), which present in each monomer are separated by 50 A˚ [22],
while native MBP-A exists as a trimer with the individualis reflected in the nanomolar dissociation constants ob-
served for CVN to the high-affinity ligands Man1- mannose binding sites separated by 55 A˚ [25]. In this
light, CVN is unique in that it possesses two carbohy-2Man, Man8 D1D3, and Man9, as well as gp120. Second,
in contrast to the strict Ca2-dependence for carbohy- drate binding sites (separated by 40 A˚) within a single
monomeric protein which facilitate divalent, and conse-drate binding observed for the C type animal lectins
(which distinguishes this family from the S type animal quently high-affinity and high-avidity, interactions.
lectins [24]), CVN requires neither Ca2 nor additional
cofactors for high-affinity carbohydrate binding. More- Biological Implications
over, there is no apparent sequence or structural homol-
ogy between CVN and other carbohydrate binding pro- The novel cyanobacterial protein CVN is currently under-
going preclinical studies as a topical anti-HIV agent dueteins. In this light, it is interesting to note one structural
feature shared by the carbohydrate binding sites of both to its ability to potently inhibit all strains of HIV at the
level of viral entry. CVN contains two symmetry-relatedCVN and MBP-A; apparent from the cocrystal structure
of MBP-A in complex with Man6GlcNAc2, the carbohy- carbohydrate binding sites of differing affinities that se-
lectively bind with nanomolar affinity to the high-man-drate binding site is formed by a tetrad of opposing pairs
of asparagine and glutamate residues, the sidechains nose structures Man8 D1D3 and Man9, as well as the
terminal disaccharide Man1-2Man which comprisesof which ligate a single Ca2 ion (which stabilizes the
carbohdyrate binding pocket) and mediate binding to the terminal branches of Man8 D1D3 and Man9. Similarly,
CVN binds to the HIV viral envelope glycoprotein gp120an -mannopyranose ring illustrated in Figure 5a [23].
As seen in Figure 5b, a similar arrangement of polar with nanomolar affinity, and the binding is mediated by
these same CVN-oligomannose interactions. In order toresidues is seen in the high-affinity binding site of CVN
and formed by the opposing side chains of Asn42 and determine the structural basis for the potent anti-HIV
activity of CVN, we have solved the solution structure ofAsn53, and Glu41 and Glu56. However, unlike the equiv-
alent amino acids in MBP-A, in CVN this tetrad partici- a 1:2 CVN:Man1-2Man complex. In contrast to other
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Figure 5. Comparison of Carbohydrate Bind-
ing Sites in MBP-A and CVN
(a) Carbohydrate-recognition domain of the
MBP-A:Man6GlcNAc2 cocrystal complex (PDB
accession code 2MSB) in which the -man-
nopyranose ring corresponding to either the
Man B or Man C ring (see Figure 1d) of
Man6GlcNAc2 is shown in a ball-and-stick
representation with carbon and oxygen
atoms colored black and red, respectively.
Glutamate side chains are colored red, aspar-
agine side chains are blue, and the Ca2 ion
is shown as a cyan sphere.
(b) A similar representation is shown for the
high-affinity CVN:Man1-2Man complex that
does not require Ca2.
Experimental Procedurescarbohydrate binding proteins, the structure of the high-
affinity complex reveals a deep polar carbohydrate binding
Expression, Purification, and Sample Preparationpocket that envelops the disaccharide and is stabilized by
Recombinant CVN (encoded by a synthetic gene inserted into pET-
numerous electrostatic, as well as several hydrophobic, 11a) was expressed, uniformly labeled with 15N (95%) and 13C
interactions. The model of the lower-affinity site clarifies (95%), and purified as described previously [6, 7]. NMR samples
comprised complexes of 1 mM 15N-CVN or 13C/15N-CVN to 1 orthe differences in affinity observed for the two sites
2 mM Man1-2Man in 10 mM phosphate buffer (pH 6.4). Man1-and reveals a deep cleft that partially surrounds the
2Man was purchased from Sigma (St. Louis) and judged to bedisaccharide. Although the low-affinity site in CVN binds
98% pure by 1H NMR and FABMS.Man1-2Manwith an10-fold decrease in affinity rela-
tive to the high-affinity site [4], it is noteworthy that both
NMR Spectroscopysites exhibit dramatically higher affinities for a disaccha-
All NMR experiments were recorded at 27C on Bruker DMX500ride than other mannose-specific lectins, which typically
and DMX600 spectrometers equipped with x,y,z-shielded gradient
bind their carbohydrate ligands with 0.1–10 mM dissoci- triple-resonance probes. Spectra were processed with the NMRPipe
ation constants. CVN provides the first example of a package [26] and analyzed with the programs PIPP and CAPP [27].
1H, 13C, and 15N assignments for the protein were made for the 1:1monomeric carbohydrate binding protein capable of di-
and 1:2 CVN:Man1-2Man complexes using 3D double- and triple-valent binding due to the presence of two carbohydrate
resonance through bond correlation and NOE experiments [28]. 1Hbinding sites within one protein. Moreover, the spacing
resonance assignments for the disaccharide were made from 12Cof the binding sites furnishes a simple structural model
filtered HOHAHA and NOESY spectra for both the 1:1 and 1:2
for monovalent or divalent binding of CVN to gp120 CVN:Man1-2Man complexes. 3J couplings for side chains were
that is consistent with reported biochemical findings. obtained by quantitative J correlation spectroscopy [12]. Interproton
distance restraints were derived from the following experiments;In addition to yielding a new high-affinity carbohydrate
intramolecular NOEs within the protein were made from a 3D 15Nbinding motif, the structure of the CVN:Man1-2Man
separated NOE (120 ms mixing time) experiment, intramolecularcomplex described here presents a new class of carbo-
NOEs within the disaccharide (both 1:1 and 1:2 CVN:Man1-2Manhydrate binding protein and suggests that a more potent
complexes) were made from a 12C filtered NOE experiment, and
inhibitor might be constructed by altering the low-affinity intermolecular NOEs between protein and disaccharide were made
site to more closely match the composition of the high- from 3D 12C filtered/13C separated NOE experiments (150 ms and
250 ms mixing times) performed on each of the complexes. Residualaffinity site.
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